Risk Factors Associated With Cardiovascular Events During Testosterone Administration in Older Men With Mobility Limitation
Authors:
Open Access
- 4 May 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 68 (2) , 153-160
Abstract
Testosterone in Older Men with Mobility Limitations Trial found an increased incidence of cardiovascular events in men randomized to testosterone, resulting in enrollment cessation by trial's Data and Safety Monitoring Board. We evaluated changes in gonadal hormones and markers of inflammation and coagulation to elucidate risk factors associated with cardiovascular events. Men aged 65 years or more, with mobility limitation, total testosterone 100–350 ng/dL, or free testosterone less than 50 pg/mL, were randomized to placebo or 10 g testosterone gel daily for 6 months. Changes in total and free testosterone, estradiol and estrone, C-reactive protein, interleukin 6, fibrinogen, plasminogen activator inhibitor-1, and pro-brain naturetic peptide were compared between groups and within the testosterone group between subjects who experienced cardiovascular events and those who did not. Of 209 men randomized (mean age 74 years), gonadal hormones and biomarkers were available in 179 men. Baseline body mass index, gonadal hormones, lipids, Framingham risk scores, and other biomarkers were similar in the two treatment groups. Within the testosterone group, the 6-month increase in free testosterone was significantly greater in men who experienced cardiovascular events than in those who did not [mean (95% confidence interval), 10.6 (4.6–16.7) vs 5.2 (3.0–7.5) ng/dL, p = .05]. In multivariable logistic regression analysis, the change in the serum levels of free testosterone was associated with cardiovascular events. Mobility-limited older men who experienced cardiovascular events had greater increases in serum free testosterone levels than those who did not.Keywords
This publication has 40 references indexed in Scilit:
- The Lifestyle Interventions and Independence for Elders Study: Design and MethodsThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2011
- Clinical Meaningfulness of the Changes in Muscle Performance and Physical Function Associated With Testosterone Administration in Older Men With Mobility LimitationThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2011
- Adverse Events Associated with Testosterone AdministrationNew England Journal of Medicine, 2010
- Effects of testosterone therapy on muscle performance and physical function in older men with mobility limitations (The TOM Trial): Design and methodsContemporary Clinical Trials, 2009
- Estradiol and Inflammatory Markers in Older MenThe Journal of Clinical Endocrinology & Metabolism, 2009
- Left ventricular early myocardial dysfunction after chronic misuse of anabolic androgenic steroids: a Doppler myocardial and strain imaging analysisBritish Journal of Sports Medicine, 2006
- Estradiol increases platelet aggregation in PlA1/A1 individualsAmerican Heart Journal, 2006
- Castration reduces platelet thromboxane A2 receptor density and aggregabilityQJM: An International Journal of Medicine, 2005
- Anabolic Androgenic Steroids Produce Dose-Dependent Increase in Left Ventricular Mass in Power Athletes, and this Effect is Potentiated by Concomitant Use of Growth HormoneInternational Journal of Sports Medicine, 2003
- Parenteral polyoestradiol phosphate vs orchidectomy in the treatment of advanced prostatic cancer. Efficacy and cardiovascular complications: a 2‐year follow‐up report of a national, prospective prostatic cancer studyBritish Journal of Urology, 1998